| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645567 | Annals of Allergy, Asthma & Immunology | 2016 | 6 Pages |
Abstract
Serologic testing for strongyloides may be indicated for patients with allergy-type symptoms and a suggestive exposure history. Patients with strongyloidiasis and primarily cutaneous symptoms experienced significant symptomatic improvement after ivermectin therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Lahari MBBS, Sunit P. MD, Golda MD, David L. MD, Gabriele MD,